Last reviewed: July 6, 2026
Last updated: July 6, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in Ozempic, has become one of the most talked-about medications for weight loss in recent years. In clinical trials, patients taking semaglutide lost an average of 15% of their body weight over 68 weeks—significantly more than diet and exercise alone. However, whether Ozempic itself is right for you depends on your individual health profile, goals, and access to treatment.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
How Does Semaglutide Actually Work for Weight Loss?
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, which means it mimics a natural hormone your body produces to regulate blood sugar and appetite. When semaglutide binds to GLP-1 receptors in your brain, it signals fullness and reduces hunger—making you feel satisfied with smaller meals and fewer snacks throughout the day. This mechanism also slows gastric emptying, keeping food in your stomach longer and extending the feeling of satiety.
The medication also appears to influence reward pathways in the brain, reducing cravings for high-calorie foods. Research shows that patients on semaglutide report decreased interest in foods they previously craved, which supports sustained weight loss rather than temporary restriction. This dual action—reduced hunger plus reduced cravings—explains why semaglutide users often achieve better long-term outcomes than with diet alone.
What Do Clinical Trials Show About Semaglutide Weight Loss Results?
The STEP trials (Semaglutide Treatment Effect in People with obesity) involved over 4,500 participants and measured real-world weight loss outcomes. Participants receiving the highest dose of semaglutide lost approximately 18% of their initial body weight, compared to only 3% in the placebo group—a difference of 15 percentage points. These results held true across diverse populations, including those with type 2 diabetes and those without.
Beyond the headline number, clinical data shows that semaglutide users maintained their weight loss throughout the trial period, suggesting the effects are sustainable as long as treatment continues. Importantly, weight loss typically plateaus around 6 months of consistent treatment, and then remains stable. Most patients experience maximum benefit at higher doses, but meaningful weight loss begins at lower doses and increases gradually as your body adjusts.
Why Some People Don't Lose Weight on Semaglutide
Not everyone loses significant weight on semaglutide, and several factors influence individual response. Dosing is critical—patients who remain on starter doses may see modest results, while those who advance to therapeutic doses typically experience greater weight loss. Additionally, baseline metabolic health, insulin sensitivity, and genetics all play a role in how your body responds to GLP-1 receptor activation.
The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
Ozempic vs. Compounded Semaglutide: What's the Difference?
Ozempic is an FDA-approved branded injectable formulation of semaglutide manufactured by Novo Nordisk, designed specifically for type 2 diabetes management. Compounded semaglutide is manufactured by licensed 503A compounding pharmacies using the same active pharmaceutical ingredient, but prepared in a pharmacy setting and typically prescribed off-label for weight loss. The active medication is identical, but compounded versions cost significantly less and don't require insurance coverage.
PlexusDx partners with licensed 503A compounding pharmacies to deliver personalized semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan—with pricing that doesn't change as your dose increases. The service is available in all 50 states without insurance, membership fees, or prior authorization delays. Many patients choose compounded semaglutide for cost and accessibility while maintaining the same clinical efficacy as branded Ozempic.
How Long Before You See Weight Loss Results?
Most patients begin noticing decreased appetite within 1–2 weeks of starting semaglutide, though actual weight loss typically becomes measurable around week 4. The first noticeable changes often include eating less at meals, fewer cravings between meals, and a shift in food preferences toward lighter foods. Weight loss accelerates as you advance through higher doses, with the most significant reductions occurring between weeks 8 and 24 of treatment.
Individual timelines vary based on starting dose, dose escalation schedule, and baseline weight. Patients starting at the standard $149/month entry price begin with lower doses and titrate upward every 4 weeks to allow the body to adapt and minimize side effects. By month 3 or 4, most patients reach therapeutic doses where substantial weight loss becomes evident. Patience is essential—semaglutide is a long-term treatment designed for sustained results rather than rapid changes.
What Are the Most Common Side Effects?
Nausea is the most frequently reported side effect, occurring in about 25–40% of patients, particularly when starting treatment or advancing doses. Nausea typically peaks within the first few days of a new dose and subsides within a week as your body adjusts. Other common side effects include vomiting, constipation, diarrhea, and mild abdominal discomfort—all of which tend to be temporary and manageable with proper hydration and gradual dose increases.
Serious adverse effects are rare but can include pancreatitis symptoms, severe allergic reactions, and thyroid concerns in patients with personal or family thyroid cancer history. Patients should report persistent severe pain in the upper abdomen, unexplained vomiting, or signs of allergic reaction immediately to their healthcare provider. Most side effects resolve within 2–3 weeks, and many patients experience minimal adverse effects as doses stabilize.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.
Frequently Asked Questions
Will I lose weight immediately after starting semaglutide?
Most patients notice reduced appetite within 1–2 weeks, but measurable weight loss typically appears after 4 weeks of consistent treatment. Maximum weight loss occurs between weeks 8 and 24 as doses advance to therapeutic levels. Individual results vary based on genetics, dosing, and lifestyle factors.
How much weight can I expect to lose on semaglutide?
No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Is compounded semaglutide from PlexusDx as effective as Ozempic?
Yes—compounded semaglutide contains the identical active pharmaceutical ingredient as Ozempic and produces the same clinical results. PlexusDx sources from licensed 503A compounding pharmacies and delivers personalized injectable semaglutide at $189/mo month-to-month, or from $149/mo on the 6-month plan without insurance, membership fees, or dosing surprises.
What happens to my weight if I stop taking semaglutide?
Most patients begin regaining weight within weeks of stopping semaglutide, as appetite and cravings return to baseline levels. Long-term weight maintenance typically requires ongoing treatment. Some patients transition to lower maintenance doses rather than stopping completely, which helps preserve weight loss at lower cost.
How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?
No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What Food Works Like Ozempic: Unlocking Your Body’s Natural Fullness Signals
Where to Inject Wegovy: Your Comprehensive Guide to Effective Administration